共 146 条
[1]
Lutgring JD(2019)Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat Semin Diagn Pathol 36 182-186
[2]
Escandon-Vargas K(2017)The epidemiology of carbapenemases in Latin America and the Caribbean Expert Rev Anti-Infect Ther 15 277-297
[3]
Reyes S(2012)Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 18 54-60
[4]
Gutierrez S(2008)Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies Infect Control Hosp Epidemiol 29 1099-1106
[5]
Villegas MV(2016)Characterization and clinical impact of bloodstream infection caused by Carbapenemase-producing Enterobacteriaceae in seven Latin American countries PLoS One 11 1319-1328
[6]
Ben-David D(2017)Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis Infect Control Hosp Epidemiol 38 1170-1175
[7]
Kordevani R(2014)Deaths attributable to carbapenem-resistant Enterobacteriaceae infections Emerg Infect Dis 20 288-289
[8]
Keller N(2016)Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1 Lancet Infect Dis 16 161-168
[9]
Tal I(2016)Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study Lancet Infect Dis 16 711-718
[10]
Marzel A(2017)Colistin resistance in Carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64 80-149